PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15388777-5	2004	Diazoxide completely blocked both elevation of [Ca(2)(+)](c) and translocation of PKC-alpha-EGFP.	Diazoxide	0-9	protein kinase C, alpha	Rattus norvegicus	82-96	
11435343-7	2001	Subcellular localization of PKC isoforms by Western blot analysis and immunocytochemistry demonstrated that PKC-alpha and PKC-delta were translocated to the sarcolemma and that PKC-delta was translocated to the mitochondria after diazoxide treatment.	Diazoxide	230-239	protein kinase C, alpha	Rattus norvegicus	28-31	
11435343-7	2001	Subcellular localization of PKC isoforms by Western blot analysis and immunocytochemistry demonstrated that PKC-alpha and PKC-delta were translocated to the sarcolemma and that PKC-delta was translocated to the mitochondria after diazoxide treatment.	Diazoxide	230-239	protein kinase C, alpha	Rattus norvegicus	108-117	
11435343-9	2001	In PKC-downregulated hearts, protection was abolished because mitoK(ATP) channels could not be activated by diazoxide.	Diazoxide	108-117	protein kinase C, alpha	Rattus norvegicus	3-6	
10347090-9	1999	The addition of sodium 5-hydroxydecanoate, a specific MitoKATP channel inhibitor, or chelerythrine chloride, a PKC inhibitor, during diazoxide pretreatment completely abolished the beneficial effects of diazoxide on the Ca2+ PD.	Diazoxide	133-142	protein kinase C, alpha	Rattus norvegicus	111-114	
10347090-9	1999	The addition of sodium 5-hydroxydecanoate, a specific MitoKATP channel inhibitor, or chelerythrine chloride, a PKC inhibitor, during diazoxide pretreatment completely abolished the beneficial effects of diazoxide on the Ca2+ PD.	Diazoxide	203-212	protein kinase C, alpha	Rattus norvegicus	111-114	
22886957-8	2012	In diazoxide-treated normal ASMCs, the R-123 fluorescence intensity, protein and mRNA levels of PKCalpha, MTT A values and percentage of cells in S phase were markedly increased as compared with untreated controls.	Diazoxide	3-12	protein kinase C, alpha	Rattus norvegicus	96-104	
22886957-11	2012	In untreated and diazoxide-treated ASMCs of asthmatic rats, the R-123 fluorescence intensity, protein and mRNA levels of PKCalpha, MTT A values and the percentage of cells in S phase were increased in comparison to the normal control group.	Diazoxide	17-26	protein kinase C, alpha	Rattus norvegicus	121-129